BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7738337)

  • 1. Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit.
    Durand-Gasselin B; Leclercq R; Girard-Pipau F; Deharvengt MC; Rochant H; Astier A; Duval J; Cordonnier C
    J Hosp Infect; 1995 Jan; 29(1):19-33. PubMed ID: 7738337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
    Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
    Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units.
    Fomsgaard A; Høiby N; Friis HM; Gahrn-Hansen B; Kolmos HJ; Schouenborg P; Korsager B; Tvede M; Gutschik E; Bremmelgaard A
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):275-81. PubMed ID: 7649189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988.
    Phillips I; King A; Gransden WR; Eykyn SJ
    J Antimicrob Chemother; 1990 Apr; 25 Suppl C():59-80. PubMed ID: 2112124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
    J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility patterns of bacterial isolates from intensive care and haematology/oncology patients in New Zealand.
    Morris AJ; Bremmer DA; Jones MR; Schousboe MI
    N Z Med J; 1997 May; 110(1044):187-9. PubMed ID: 9201205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of drug resistance spectrum and its mechanism in 1017 clinical bacterial isolates].
    Geng SN; Rui YY; Wang Q; Mou CH; Zhou XH; Zhang J
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1529-32, 1545. PubMed ID: 16361155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy.
    Kresken M; Hafner D
    Infection; 1999; 27 Suppl 2():S2-8. PubMed ID: 10885818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
    Courtieu AL; Drugeon H; Billaudel S
    Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey.
    Decousser JW; Pina P; Picot F; Delalande C; Pangon B; Courvalin P; Allouch P;
    J Antimicrob Chemother; 2003 May; 51(5):1213-22. PubMed ID: 12697655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America).
    Kirby JT; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):75-82. PubMed ID: 16876375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
    Fass RJ; Barnishan J; Ayers LW
    J Antimicrob Chemother; 1995 Aug; 36(2):343-53. PubMed ID: 8522464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.